The design of molecules able to interact with the amyloid peptides either as inhibitors of fibril formation or as inhibitors of amyloid membrane pore formation represents one of the most relevant approaches in the development of anti-Alzheimer therapies. Abeta-(25-35), sequence GSNKGAIIGLM, is a highly toxic synthetic derivative of amyloid beta-peptides (Abeta-peptides), which forms fibrillary aggregates. Here, we report the NMR and CD investigation of Abeta-(25-35) in a membrane-mimicking environment and in isotropic mixtures of water and fluoroalcohols to scan its conformational properties as a function of the medium. The analysis of the 3D structures in the mentioned conditions indicates a propensity of the peptide to behave as a typical...
Current views of the role of b-amyloid (Ab) peptide fibrils range from regarding them as the cause ...
The 39-42 amino acid long, amphipathic amyloid-beta peptide (Abeta) is one of the key components inv...
Structures of amyloid-beta peptides Aβ1-40. Aβ10-35, β13-23 and Aβ16-22 in a complex with model memb...
The design of molecules able to interact with the amyloid peptides either as inhibitors of fibril fo...
The design of molecules able to interact with the amyloid peptides either as inhibitors of fibril fo...
The design of molecules able to interact with the amyloid peptides either as inhibitors of fibril f...
The major components of neuritic plaques found in Alzheimer disease (AD) are eptides known as amyloi...
Current views of the role of beta-amyloid (Abeta) peptide fibrils range from regarding them as the c...
The three-dimensional solution structure of the 40 residue amyloid beta-peptide, A beta(1-40), has b...
Current views of the role of beta-amyloid (A beta) peptide fibrils range from regarding them as the ...
The major components of neuritic plaques found in Alzheimer disease (AD) are peptides known as amyl...
Abeta (16-35) is the hydrophobic central core of beta-amyloid peptide, the main component of plaques...
Current views of the role of b-amyloid (Ab) peptide fibrils range from regarding them as the cause ...
The 39-42 amino acid long, amphipathic amyloid-beta peptide (Abeta) is one of the key components inv...
Structures of amyloid-beta peptides Aβ1-40. Aβ10-35, β13-23 and Aβ16-22 in a complex with model memb...
The design of molecules able to interact with the amyloid peptides either as inhibitors of fibril fo...
The design of molecules able to interact with the amyloid peptides either as inhibitors of fibril fo...
The design of molecules able to interact with the amyloid peptides either as inhibitors of fibril f...
The major components of neuritic plaques found in Alzheimer disease (AD) are eptides known as amyloi...
Current views of the role of beta-amyloid (Abeta) peptide fibrils range from regarding them as the c...
The three-dimensional solution structure of the 40 residue amyloid beta-peptide, A beta(1-40), has b...
Current views of the role of beta-amyloid (A beta) peptide fibrils range from regarding them as the ...
The major components of neuritic plaques found in Alzheimer disease (AD) are peptides known as amyl...
Abeta (16-35) is the hydrophobic central core of beta-amyloid peptide, the main component of plaques...
Current views of the role of b-amyloid (Ab) peptide fibrils range from regarding them as the cause ...
The 39-42 amino acid long, amphipathic amyloid-beta peptide (Abeta) is one of the key components inv...
Structures of amyloid-beta peptides Aβ1-40. Aβ10-35, β13-23 and Aβ16-22 in a complex with model memb...